DCM vs HIT โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
HIT Captures Institutional Edge (2โ2 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Health In Tech, Inc. Class A Common Stock (HIT) driven by superior Valuation, Growth & Margin while DCM counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, DCM trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus HIT at 8.8x Forward P/E and -45.8% operating margin (-22.4% YoY). In options structure, DCM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against HIT sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | DCM | HIT | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $27.1M | Larger Scale | HIT |
| Trailing P/E Ratio Valuation | N/M | 8.8x | Lower Multiple | HIT |
| Forward P/E Ratio Valuation | N/M | 8.8x | Lower Multiple | HIT |
| Revenue Growth (YoY) Growth | N/A | -22.4% | Higher Growth | HIT |
| Operating Margin (TTM) Profitability | N/A | -45.8% | Higher Margin | HIT |
| Net Profit Margin Profitability | N/A | -37.1% | Higher Margin | HIT |
| Return on Equity (ROE) Capital Efficiency | N/A | -76.6% | Higher ROE | HIT |
| 52-Week Range Position Momentum | 0% ($3โ$5) | 5% ($0โ$2) | Stronger Trend | HIT |
| Beta / 30D Volatility Risk Regime | N/A | 0.95ฮฒ ยท 152% Vol | Lower Realized Risk | DCM |
| Unified Institutional Score Composite Signal | 48.8 / 100 (HOLD) | 39.6 / 100 (SELL) | Higher Composite | DCM |